Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.

Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA. · 2018

Read Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. by Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6048712.txt.

Description

Capone and co-authors test a blood ratio as a survival marker in melanoma. Their study appeared in the Journal for Immunotherapy of Cancer. The marker is the neutrophil-to-lymphocyte ratio. High values have predicted poor outcomes in many cancers. The patients here received the drug nivolumab.

The analysis covered 97 patients with stage IV melanoma. Blood counts were taken before treatment began. Higher ratios tracked with shorter survival in the data. A derived version of the ratio also worked. Cutoff values separated better and worse outcome groups. One enzyme, LDH, also kept its predictive value. Both markers are cheap and easy to obtain. The authors suggest them for judging likely response. Readers get a simple tool for immunotherapy planning.

Catalog record

CREATORCapone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6048712

Browse the full library · About the Tower of Babel